Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Static UnitedHealth Group Inc Stock Doesn’t Offer Much Upside

By Josh Enomoto, InvestorPlace Contributor

UnitedHealth Group’s aggressive business strategy should boost UNH stock, but rising costs weigh heavily on shares.

General Electric Company Stock Is so Terrible, It’s Too Risky to Short

By Josh Enomoto, InvestorPlace Contributor

Everybody is pounding on GE stock without mercy, but this is exactly why investors should hesitate on the obvious trade.

Intel Corporation Stock Walks the Walk, and Its Fundamentals Prove It

By Josh Enomoto, InvestorPlace Contributor

The Intel stock price has been a pleasant surprise amid broader market concerns, but investors should really focus on the INTC fundamentals.

3 Reasons Why World Wrestling Entertainment, Inc. Stock Will Suffer a Smack Down

By Josh Enomoto, InvestorPlace Contributor

WWE stock has been a shocker of Wall Street, but despite some positive catalysts, World Wrestling Entertainment's headwinds are too severe to overcome.

Pfizer Inc. Stock Has a Great Storyline That’s Not Panning Out

By Josh Enomoto, InvestorPlace Contributor

Pfizer implemented different strategies to cope with its loss of patent exclusivity, but unfortunately, PFE stock remains deflated.

Load More